Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
Income Statement [Abstract]
Net Sales	$ 2,634,181	$ 2,783,240	$ 8,785,114	$ 7,587,513
Cost of Sales	1,389,328	1,545,970	4,609,583	4,248,305
Gross Profit	1,244,853	1,237,270	4,175,531	3,339,208
Operating Expenses:
Selling, general and administrative expenses	2,563,726	2,401,289	8,072,562	6,471,723
Loss from Operations	(1,318,873)	(1,164,019)	(3,897,031)	(3,132,515)
Other Income (Expense):
Other income	1,300	842	5,058	3,639
Interest expense	(288,631)	(173,681)	(867,213)	(379,355)
Total Other Expense	(287,331)	(172,839)	(862,155)	(375,716)
Net Loss	(1,606,204)	(1,336,858)	(4,759,186)	(3,508,231)
Series B convertible contractual dividends	(65,271)	(61,000)	(195,813)	(183,000)
Series C redeemable deemed dividends	(247,774)		(433,606)
Loss Attributable to Common Stockholders	$ (1,919,249)	$ (1,397,858)	$ (5,388,605)	$ (3,691,231)
Per Share Data:
Net loss per common share - basic and diluted	$ (0.14)	$ (0.13)	$ (0.44)	$ (0.33)
Contractual dividends	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Deemed dividends	$ (0.02)		$ (0.04)
Net loss attributable to common stockholders per share - basic and diluted	$ (0.16)	$ (0.14)	$ (0.50)	$ (0.35)
Weighted Average Number of Common Shares Outstanding - basic and diluted	11,741,437	10,551,520	10,736,828	10,545,466